Chronic myelomonocytic leukaemia - azacitidine - initial authority application form (PB079)

Use this form to apply for initial PBS-subsidised treatment with azacitidine for chronic myelomonocytic leukaemia.

Page last updated: 1 June 2025.
QC 20766